Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of C-Myc Via Targeting the Wnt/β-Catenin Signaling Pathway

Overview

Journal Nutrients

Date 2022 Jul 27

PMID 35893895

Authors

Jun Chen

Zhiguang Duan

Yannan Liu

Rongzhan Fu

Chenhui Zhu

Affiliations

Soon will be listed here.

Abstract

The metastasis of esophageal squamous cell carcinoma (ESCC) is a leading cause of death worldwide, however, it has a poor prognosis. Ginsenoside Rh4 is a rare saponin that has been shown to have potential antitumor effectiveness in ESCC. However, the utility of Rh4 in ESCC metastasis and its undiscovered mode of action has not yet been explored. In this study, we found that Rh4 could inhibit ESCC metastasis by regulating the Wnt/β-catenin signaling pathway and the level of c-Myc, which is an important transcription factor in cancer. In in vitro experiments, Rh4 could inhibit the migration and invasion of ESCC cells without affecting cell viability. In in vivo experiments, Rh4 restrained ESCC metastasis to the lymph nodes and lungs via the suppression of epithelial-mesenchymal transition (EMT). The Wnt agonist HLY78 promoted EMT and migration of ESCC cells, whereas treatment of Rh4 can attenuate the promotion effect of HLY78. The siRNA knocking out c-Myc can also significantly reduce the expression of EMT-related marker proteins. This study illustrates a new concept for further research on the mechanism of Rh4 in ESCC.

Citing Articles

Discovery of Crinasiadine, Trisphaeridine, Bicolorine, and Their Derivatives as Anti-Tobacco Mosaic Virus (TMV) Agents.

Hu Z, Guo J, Ma D, Wang Z, Liu Y, Wang Q Int J Mol Sci. 2025; 26(3).

PMID: 39940870 PMC: 11816930. DOI: 10.3390/ijms26031103.

AP001885.4 promotes the proliferation of esophageal squamous cell carcinoma cells by histone lactylation- and NF-κB (p65)-dependent transcription activation and METTL3-mediated mRNA stability of c-myc.

Fu C, Jiang W, Wang C, Song S, Tao H, Zhang X Anim Cells Syst (Seoul). 2024; 28(1):536-550.

PMID: 39502790 PMC: 11536669. DOI: 10.1080/19768354.2024.2417458.

Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential.

Zhao X, Ma Y, Luo J, Xu K, Tian P, Lu C Heliyon. 2024; 10(16):e35989.

PMID: 39253139 PMC: 11381626. DOI: 10.1016/j.heliyon.2024.e35989.

Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells.

Lee J, Lee H J Ginseng Res. 2024; 48(3):266-275.

PMID: 38707642 PMC: 11068999. DOI: 10.1016/j.jgr.2024.03.003.

SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms.

Wang T, Jin Y, Wang M, Chen B, Sun J, Zhang J Mol Med. 2024; 30(1):46.

PMID: 38584262 PMC: 11000312. DOI: 10.1186/s10020-024-00812-z.

References

Wei W, Liu H, Yuan J, Yao Y . Targeting Wnt/β-catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer. Fundam Clin Pharmacol. 2020; 35(1):165-173. DOI: 10.1111/fcp.12583. View

Lee H, Cha J, Kim S, Park J, Song K, Kim P . c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL. Mol Cancer Res. 2018; 17(2):544-554. DOI: 10.1158/1541-7786.MCR-18-0630. View

Chen C, He W, Huang J, Wang B, Li H, Cai Q . LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun. 2018; 9(1):3826. PMC: 6148066. DOI: 10.1038/s41467-018-06152-x. View

Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M . Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2015; 149(7):1700-15. DOI: 10.1053/j.gastro.2015.08.054. View

Orang A, Petersen J, McKinnon R, Michael M . Micromanaging aerobic respiration and glycolysis in cancer cells. Mol Metab. 2019; 23:98-126. PMC: 6479761. DOI: 10.1016/j.molmet.2019.01.014. View

Bisso A, Filipuzzi M, Gamarra Figueroa G, Brumana G, Biagioni F, Doni M . Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz. Hepatology. 2020; 72(4):1430-1443. DOI: 10.1002/hep.31120. View

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

Wang Q, Lv Q, Bian H, Yang L, Guo K, Ye S . A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer. Cancer Med. 2019; 8(5):2360-2371. PMC: 6537088. DOI: 10.1002/cam4.2078. View

Theveneau E, Mayor R . Cadherins in collective cell migration of mesenchymal cells. Curr Opin Cell Biol. 2012; 24(5):677-84. PMC: 4902125. DOI: 10.1016/j.ceb.2012.08.002. View

10.

Hecht J, Bang Y, Qin S, Chung H, Xu J, Park J . Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial. J Clin Oncol. 2015; 34(5):443-51. DOI: 10.1200/JCO.2015.62.6598. View

11.

Wang Q, Cheng Y, Wang Y, Fan Y, Li C, Zhang Y . Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells. BMC Cancer. 2017; 17(1):492. PMC: 5518097. DOI: 10.1186/s12885-017-3457-4. View

12.

Huang T, Fu L . The immune landscape of esophageal cancer. Cancer Commun (Lond). 2019; 39(1):79. PMC: 6878621. DOI: 10.1186/s40880-019-0427-z. View

13.

Lam S, Guchelaar H, Boven E . The role of pharmacogenetics in capecitabine efficacy and toxicity. Cancer Treat Rev. 2016; 50:9-22. DOI: 10.1016/j.ctrv.2016.08.001. View

14.

Kai F, Drain A, Weaver V . The Extracellular Matrix Modulates the Metastatic Journey. Dev Cell. 2019; 49(3):332-346. PMC: 6527347. DOI: 10.1016/j.devcel.2019.03.026. View

15.

Chen D, Zhang H, Jing C, He X, Yang B, Cai J . Efficient synthesis of new phenanthridine Wnt/β-catenin signaling pathway agonists. Eur J Med Chem. 2018; 157:1491-1499. DOI: 10.1016/j.ejmech.2018.08.064. View

16.

Hu M, Yang J, Qu L, Deng X, Duan Z, Fu R . Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. Food Funct. 2019; 11(1):456-471. DOI: 10.1039/c9fo02166c. View

17.

Wang W, He S, Zhang R, Peng J, Guo D, Zhang J . ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin. Biomed Pharmacother. 2020; 125:109940. DOI: 10.1016/j.biopha.2020.109940. View

18.

Yang S, Li X, Shen W, Hu H, Li C, Han G . MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway. J Surg Res. 2020; 257:267-277. DOI: 10.1016/j.jss.2020.07.074. View

19.

Ren Y, Guo T, Xu J, Liu Y, Huang J . The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling. Pathol Res Pract. 2020; 217:153289. DOI: 10.1016/j.prp.2020.153289. View

20.

Luo X, Li L, Xu W, Cheng Y, Xie Z . HLY78 Attenuates Neuronal Apoptosis via the LRP6/GSK3β/β-Catenin Signaling Pathway After Subarachnoid Hemorrhage in Rats. Neurosci Bull. 2020; 36(10):1171-1181. PMC: 7532258. DOI: 10.1007/s12264-020-00532-4. View